We therefore addressed the questions whether absence of Slc26a9 expression may promote gastric carcinogenesis in mice, whether a selective loss of Slc26a9 in parietal cells may be sufficient to induce metaplasia and, ultimately, GC. The gene discussed is SLC26A9; the disease is gastric cancer.